ArticleSurgery in practice and science2026
Combined Impact of Cannabinoids and Cocaine on Outcomes of Trauma Patients.
Article in Surgery in practice and science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: In recent years, the use of polypharmacy has surged. There is a gap in knowledge regarding the impact of pre-injury use of polypharmacy on outcomes. The purpose of the study was to evaluate the effects of cannabinoids (CANB) and cocaine (COC) on trauma patients' outcomes. The hypothesis is, no difference in-hospital mortality in patients who tested positive for CANB+COC versus those who only tested positive for CANB. Methods: The Trauma Quality Improvement Program (TQIP) for 2019-2023 dataset was used. Patients' demography, clinical characteristics, injury type and severity, and outcomes were compared between patients who tested positive for CANB+COC and those who tested positive only for CANB. Propensity score matching methodology was used to obtain the results. A p-value < 0.05 was considered statistically significant. Results: Out of 120,951 patients who qualified for the study, 12,116 pairs of patients were obtained from the propensity score matching process. Most of the baseline characteristics of the two groups, CANB+COC versus CANB, had no significant difference in age (years) (median [IQR]: 37 [28 - 51] vs. 32 [23 - 51]) or sex (male: 81% vs. 76.6%), ISS score (median [IQR]: 9 [5 - 17] vs. 10 [5 - 17]. Pair-matched analysis showed no significant difference in in-hospital mortality (2.2% vs. 2.2%, Conclusion: No significant association was observed between the in-hospital mortality and combined use of, CANB+COC when compared to only CANB use. However, combined drug usage was associated with a longer length of hospital stay.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.